Find uplifting stories about heroes, innovations, and solutions
8814 results for "lung cancer recovery"
A promising new pill shrank tumors in nearly two-thirds of lung cancer patients and 40% of pancreatic cancer patients in early trials. The results exceeded expectations and could offer fresh hope for people facing these difficult diagnoses.
A new pill targeting aggressive pancreatic and lung cancers showed remarkable results in early trials, shrinking tumors in nearly two-thirds of lung cancer patients. The therapy offers fresh hope for patients facing some of the deadliest cancer diagnoses.
Mayo Clinic researchers discovered that brigatinib, a lung cancer drug, may help ovarian cancer patients overcome treatment resistance when combined with existing therapies. The breakthrough could transform care for women facing one of the deadliest cancers.
A groundbreaking therapy is showing real promise against cancers long considered impossible to treat, shrinking tumors in patients who'd run out of options. The experimental drug targets a genetic mutation affecting thousands of lung and pancreatic cancer patients each year.
A new AI-powered robotic catheter is catching lung cancers as small as 6mm hidden deep in the lungs, replacing weeks of invasive testing with a single procedure. The NHS pilot has already diagnosed 215 lung cancer cases in 300 patients, detecting tumors that would have been previously impossible to reach.
A powerful new combination therapy just gained approval to help patients fighting an aggressive form of lung cancer live longer. The treatment offers hope for thousands diagnosed with extensive-stage small cell lung cancer each year.
David Peterson was given months to live when stage four lung cancer spread to both lungs, but an innovative transplant program at Northwestern Medicine gave him a second chance. He's now cancer-free years later, thanks to doctors who dared to try what was once considered impossible.
A new targeted therapy for a rare form of lung cancer just earned priority review from the FDA, potentially offering hope to thousands of patients who currently have limited treatment options. The drug specifically targets HER2 mutations found in about 2-4% of lung cancer cases.
A groundbreaking cancer treatment just showed remarkable results that exceeded doctors' expectations in treating one of the deadliest forms of lung cancer. The drug ivonescimab reduced the risk of death by 34% compared to standard treatment for patients with squamous non-small cell lung cancer.
Sanjay Dutt treated his stage 4 lung cancer diagnosis like a common flu and walked away cancer-free in just two months. His fighter mentality is inspiring survivors worldwide to face their battles head-on.
A former heavy smoker with no symptoms discovered stage three lung cancer through a free health screening in a supermarket parking lot. Since 2022, this mobile program has found over 360 lung cancers, with 77% caught in the earliest, most treatable stages.
Researchers in Hong Kong have developed the first drug that targets a specific cancer "switch" in lung cancer cells, shrinking tumors in lab tests without harming healthy tissue. The breakthrough could transform treatment for millions of people with the world's deadliest cancer.
Researchers at Stony Brook Cancer Center developed a new drug that shrank lung cancer tumors by over 95% in laboratory tests and could extend survival by years. The treatment tackles the biggest problem in cancer care: drug resistance.
Scientists at the University of Colorado have discovered how to eliminate cancer cells that survive initial treatment, potentially turning lung cancer into a curable disease. The breakthrough combines two therapies to attack cancer at its most vulnerable moment.
Two newly approved cancer treatments are giving Scottish patients hope, with one lung cancer drug reducing disease progression by 84%. The drugs offer patients more choices and better outcomes in their fight against cancer.
A newly approved lung cancer treatment offers hope for patients with a rare form of the disease, showing promising results with significantly fewer harsh side effects than existing options. The drug targets a specific genetic mutation affecting about 2% of lung cancer patients.
A groundbreaking Mount Sinai study shows that lung cancer surgery is just as safe for patients 80 and older as it is for younger adults. This finding could transform treatment options for thousands of elderly cancer patients previously considered too frail for surgery.
Researchers discovered why some lung cancer cells resist treatment and found a natural compound that could help. The breakthrough reveals a "bodyguard system" that protects cancer cells and a way to shut it down.
A breakthrough cancer treatment helped patients with advanced lung cancer live over four months longer than current therapies. The experimental drug reduced the risk of death by 34% in a study of 532 patients.
A Washington, D.C. father given little time to live after an advanced lung cancer diagnosis is now thriving thanks to a pioneering transplant surgery. The breakthrough procedure is opening doors for cancer patients who previously had no options.
Showing 20 of 8814